Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndrome

Jennifer Friedman, Lynne M Bird, Richard Haas, Shira L Robbins, Shareef A Nahas, David P Dimmock, Matthew J Yousefzadeh, Mariah A Witt, Laura J Niedernhofer, Shimul Chowdhury, Jennifer Friedman, Lynne M Bird, Richard Haas, Shira L Robbins, Shareef A Nahas, David P Dimmock, Matthew J Yousefzadeh, Mariah A Witt, Laura J Niedernhofer, Shimul Chowdhury

Abstract

Background: Cockayne syndrome (CS) is a rare autosomal recessive disorder characterized by growth failure and multisystemic degeneration. Excision repair cross-complementation group 6 (ERCC6 OMIM: *609413) is the gene most frequently mutated in CS.

Methods: A child with pre and postnatal growth failure and progressive neurologic deterioration with multisystem involvement, and with nondiagnostic whole-exome sequencing, was screened for causal variants with whole-genome sequencing (WGS).

Results: WGS identified biallelic ERCC6 variants, including a previously unreported intronic variant. Pathogenicity of these variants was established by demonstrating reduced levels of ERCC6 mRNA and protein expression, normal unscheduled DNA synthesis, and impaired recovery of RNA synthesis in patient fibroblasts following UV-irradiation.

Conclusion: The study confirms the pathogenicity of a previously undescribed upstream intronic variant, highlighting the power of genome sequencing to identify noncoding variants. In addition, this report provides evidence for the utility of a combination approach of genome sequencing plus functional studies to provide diagnosis in a child for whom a lengthy diagnostic odyssey, including exome sequencing, was previously unrevealing.

Keywords: ERCC6; DNA repair; cockayne syndrome; whole-genome sequencing.

Conflict of interest statement

Dr. Friedman holds shares in Illumina and her Spouse is Founder and Principal of Friedman Bioventure, which holds a variety of publicly traded and private biotechnology interests. Other authors have no conflicts.

© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Figures

FIGURE 1
FIGURE 1
(A) Nucleotide Excision Repair (NER) Pathway and brain imaging of patient INE4CC. Global Genome NER (left) and Transcription Coupled NER (right) converge. (B) Brain MRI and CT Scan: CT Scan age 5 (a and b) demonstrates diffuse cerebral and cerebellar atrophy. There is dense calcification of the bilateral globi pallidi and parieto‐occipital and left frontal (not shown) cortical calcification. MRI Scan age 6. T1 Images (c and d) show diffuse supra and infratentorial volume loss evidenced by ventriculomegaly, widened cortical sulci, diffuse thinning of the corpus callosum and inferior vermian and brainstem hypoplasia. There was an abnormal basal ganglia signal including mild T2 hyperintensity (not shown) T1 shortening and susceptibility artifact of the lenticular nuclei consistent with mineralization
FIGURE 2
FIGURE 2
Functional consequences of biallelic ERCC6 variants in INE4CC cells. (a) ERCC6 mRNA was quantified in patient (INE4CC) and control (C5RO) dermal fibroblasts by qRT‐PCR in triplicate using the ∆∆Ct method and normalized to GAPDH expression. (b) CSB protein levels were detected by immunoblotting of whole‐cell extracts with ⍺Tubulin as control. (c) Measurement of UV‐induced unscheduled DNA synthesis (UDS) in dermal fibroblast lines (C5RO: unaffected control; XP51RO: patient with ERCC4 mutation affecting NER; the patient in this study: INE4CC). Cells were UV‐C‐ or sham‐irradiated and then incubated with the thymidine analog EdU to allow time for DNA repair. Alexa Fluor 647 was conjugated to EdU incorporated into the nuclear genome before cell fixation, DAPI staining, and flow cytometric quantification of Alexa Fluor 647 intensity in G1 cells. UDS was measured in triplicate for each sample and normalized to the control samples. (d) Recovery of RNA synthesis in fibroblasts following UV irradiation. Expression of the house‐keeping genes DHFR and GAPDH was measured after UV‐C irradiation of cells from C5RO (normal control), XP51RO (ERCC4 mutation with a diagnosis of XFE progeroid syndrome), CS20LO (CS caused by mutations in ERCC1), and the patient in this study (INE4CC). Expression was measured at baseline (no UV) and at 6 and 24 hr postirradiation and normalized to quantity of 18s rRNA. Results were plotted as the ratio of expression in irradiated versus sham‐irradiated cells. qPCR reactions were performed in triplicate for five independent experiments. Values represent mean ± SD, ns p ≥ 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared using unpaired two‐tailed Student's t test or one‐way ANOVA with Tukey's test

References

    1. Briggs, B., James, K. N., Chowdhury, S., Thornburg, C., Farnaes, L., Dimmock, D., & Kingsmore, S. F. (2018). Novel Factor XIII variant identified through whole‐genome sequencing in a child with intracranial hemorrhage. Cold Spring Harbor Molecular Case Studies, 4(6), a003525. 10.1101/mcs.a003525.
    1. Calmels, N., Botta, E., Jia, N., Fawcett, H., Nardo, T., & Nakazawa, Y. (2018). Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome. Journal of Medical Genetics, 55(5), 329‐343. 10.1136/jmedgenet-2017-104877
    1. Colella, S., Nardo, T., Botta, E., Lehmann, A. R., & Stefanini, M. (2000). Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis‐cacchione variant of xeroderma pigmentosum. Human Molecular Genetics, 9(8), 1171–1175. 10.1093/hmg/9.8.1171
    1. Farnaes, L., Hildreth, A., Sweeney, N. M., Clark, M. M., Chowdhury, S., Nahas, S., Cakicki, J. A., Benson, W., Kaplan, R. H., Kronick, R., Bainbridge, M. N., Friedman, J., Gold, J. J., Ding, Y., Veeraraghavan, N., Dimmock, D., & Kingsmore, S. F. (2018). Rapid whole‐genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genomic Medicine, 4(3), 10. 10.1038/s41525-018-0049-4
    1. Gillet, L. C., & Schäer, O. D. (2006). Molecular mechanisms of mammalian global genome nucleotide excision repair. Chemical Reviews, 106(2), 253–276. 10.1021/cr040483f
    1. Hanawalt, P. C., & Spivak, G. (2008). Transcription‐coupled DNA repair: two decades of progress and surprises. Nature Reviews Molecular Cell Biology, 9(12), 958–970. 10.1038/nrm2549
    1. Horibata, K., Iwamoto, Y., Kuraoka, I., Jaspers, N. G., Kurimasa, A., & Oshimura, M. (2004). Complete absence of Cockayne syndrome group B gene product gives rise to UV‐sensitive syndrome but not Cockayne syndrome. Proceedings of the National Academy of Sciences of the United States of America, 101(43), 15410–15415. 10.1073/pnas.0404587101
    1. Karikkineth, A. C., Scheibye‐Knudsen, M., Fivenson, E., Croteau, D. L., & Bohr, V. A. (2017). Cockayne syndrome. Clinical Features, Model Systems and Pathways. Ageing Research Reviews, 33, 3–17. 10.1016/j.arr.2016.08.002
    1. Kashiyama, K., Nakazawa, Y., Pilz, D. T., Guo, C., Shimada, M., Sasaki, K., Fawcett, H., Wing, J. F., Lewin, S. O., Carr, L., Li, T.‐S., Yoshiura, K.‐I., Utani, A., Hirano, A., Yamashita, S., Greenblatt, D., Nardo, T., Stefanini, M., McGibbon, D., … Ogi, T. (2013). Malfunction of nuclease ERCC1‐XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. American Journal of Human Genetics, 92(5), 807–819. 10.1016/j.ajhg.2013.04.007
    1. Kleijer, W. J., Laugel, V., Berneburg, M., Nardo, T., Fawcett, H., Gratchev, A., Jaspers, N. G. J., Sarasin, A., Stefanini, M., & Lehmann, A. R. (2008). Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst), 7(5), 744–750. 10.1016/j.dnarep.2008.01.014
    1. Kou, Y., Shboul, M., Wang, Z., Shersheer, Q., Lyu, Z., Liu, P., Zhao, X., & Tian, J. (2018). Novel frame shift mutation in ERCC6 leads to a severe form of Cockayne syndrome with postnatal growth failure and early death: A case report and brief literature review. Medicine (Baltimore), 97(33), e11636. 10.1097/MD.0000000000011636
    1. Kumar, N., Raja, S., & Van Houten, B. (2020). The involvement of nucleotide excision repair proteins in the removal of oxidative DNA damage. Nucleic Acids Research, 48(20), 11227–11243. 10.1093/nar/gkaa777
    1. Laugel, V. Cockayne Syndrome. 2000 Dec 28 [Updated 2012 Jun 14]. In Adam M. P., Ardinger H. H., & Pagon R. A. et al, GeneReviews® [Internet] (pp. 1993–2019). University of Washington.
    1. Laugel, V., Dalloz, C., Durand, M., Sauvanaud, F., Kristensen, U., & Vincent, M. C. (2010). Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Human Mutation, 31(2), 113–126. 10.1002/humu.21154
    1. Laugel, V., Dalloz, C., Tobias, E. S., Tolmie, J. L., Martin‐Coignard, D., Drouin‐Garraud, V., Valayannopoulos, V., Sarasin, A., & Dollfus, H. (2008). Cerebro‐oculo‐facio‐skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. Journal of Medical Genetics, 45(9), 564–571. 10.1136/jmg.2007.057141
    1. Mori, T., Yousefzadeh, M. J., Faridounnia, M., Chong, J. X., Hisama, F. M., & Hudgins, L. (2018). ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes. Human Mutation, 39(2), 255–265. 10.1002/humu.23367
    1. Nance, M., & Berry, S. (1992). Cockayne syndrome: Review of 140 cases. American Journal of Medical Genetics, 42(1), 68–84. 10.1002/ajmg.1320420115
    1. Niedernhofer, L. J., Garinis, G. A., Raams, A., Lalai, A. S., Robinson, A. R., Appeldoorn, E., Odijk, H., Oostendorp, R., Ahmad, A., van Leeuwen, W., Theil, A. F., Vermeulen, W., van der Horst, G. T. J., Meinecke, P., Kleijer, W. J., Vijg, J., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (2006). A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature, 444(7122), 1038–1043. 10.1038/nature05456
    1. Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier‐Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424. 10.1038/gim.2015.30
    1. Schärer, O. (2013). Nucleotide excision repair in eukaryotes. Cold Spring Harbor Perspectives in Biology, 10, a012609. 10.1101/cshperspect.a012609
    1. Vélez‐Cruz, R., Zadorin, A. S., Coin, F., & Egly, J. M. (2013). Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP‐D/CS) cells. Proceedings of the National Academy of Sciences of the United States of America, 110(3), E212–220. 10.1073/pnas.1213076110
    1. Wilson, B. T., Stark, Z., Sutton, R. E., Danda, S., Ekbote, A. V., Elsayed, S. M., Gibson, L., Goodship, J. A., Jackson, A. P., Keng, W. T., King, M. D., McCann, E., Motojima, T., Murray, J. E., Omata, T., Pilz, D., Pope, K., Sugita, K., White, S. M., & Wilson, I. J. (2016). The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genetics in Medicine, 18I(5), 483–493. 10.1038/gim.2015.110

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren